0345 222 3550 Mental Health, Surgical & Ophthalmic, Palliative Care & Physical Rehabilitation
  • Home
  • About Us
  • Services
  • Resources
    • Live View
    • e-Works electronic prescribing
    • Health Awareness Resources
    • Clinical Guidelines
    • Choice & Medication
    • MaPPs (Medicines: A Patient Profile Summary)
    • NEWT Guidelines
    • Patient information leaflets
  • Order Online
  • Blog
    • Press Releases
  • Contact Us
    • Careers
    • Frequently Asked Questions
Improving quality and compliance in medicines management Improving quality and compliance in medicines management
  • Home
  • About Us
  • Services
  • Resources
    • Live View
    • e-Works electronic prescribing
    • Health Awareness Resources
    • Clinical Guidelines
    • Choice & Medication
    • MaPPs (Medicines: A Patient Profile Summary)
    • NEWT Guidelines
    • Patient information leaflets
  • Order Online
  • Blog
    • Press Releases
  • Contact Us
    • Careers
    • Frequently Asked Questions

Archives

Monthly Archive for: "July, 2011"
Home /
 NICE Care Pathways
0
By Graham Connolly
In Clinical Guidelines, NICE guidelines
Posted 27th July 2011

NICE Care Pathways

NICE has launched a new online tool for healthcare professionals, which brings together all connected NICE guidance on a topic in a user-friendly electronic flowchart. Previously, there has been [...]

READ MORE
 NICE Common Mental Health Disorders (CG 123)
0
By Graham Connolly
In Clinical Guidelines, NICE guidelines
Posted 26th July 2011

NICE Common Mental Health Disorders (CG 123)

This guidance is concerned with the identification and management of common mental health disorders such as depression, generalised anxiety disorder, panic disorder, obsessive-compulsive [...]

READ MORE
 NICE Preventing Type 2 Diabetes (PH35)
0
By Graham Connolly
In Clinical Guidelines, NICE guidelines
Posted 17th July 2011

NICE Preventing Type 2 Diabetes (PH35)

People with schizophrenia have an increased risk of cardiovascular mortality. Some atypical antipsychotics, in particular clozapine, olanzapine and quetiapine, have adverse metabolic effects such [...]

READ MORE
 Online MHRA Pharmacovigilance Training
0
By Graham Connolly
In Clinical Guidelines, MRHA News and Safety Alerts
Posted 14th July 2011

Online MHRA Pharmacovigilance Training

Pharmacovigilance is the process involving detection, assessment, understanding and prevention of adverse effects of medication. The MHRA have produced an online learning module on this topic for [...]

READ MORE
 RCPsych Standards for Adult In-Patient Mental Healthcare (OP79)
0
By Graham Connolly
In Pharmacy Information, Regulations and Standards
Posted 12th July 2011

RCPsych Standards for Adult In-Patient Mental Healthcare (OP79)

The Royal College of Psychiatrists (RCPsych) have reviewed existing standards and regulations and recommend a checklist of 10 minimum standards for assessing mental health wards. One of these [...]

READ MORE
 Shortage of Trifluoperazine (Stelazine)
0
By Graham Connolly
In Pharmacy Information, Simplifying Product Supply
Posted 11th July 2011

Shortage of Trifluoperazine (Stelazine)

There is a national shortage of trifluoperazine tablets and there will be serious supply problems for several months. Trifluoperazine liquid may be available, but alternative medication may have [...]

READ MORE
 Guidance on prescribing and using Anxiolytics and Hypnotics
0
By Graham Connolly
In Clinical Guidelines, NHS Guidelines
Posted 10th July 2011

Guidance on prescribing and using Anxiolytics and Hypnotics

The Welsh Medicines Partnership has produced a comprehensive and well-referenced educational pack (72 pages) on prescribing anxiolytics and hypnotics in primary and secondary care. It explains [...]

READ MORE
Subscribe to Ashtons Pharmacy News

Follow us
Accreditations




What is this?

Resources
Online ordering
Ashtons Live View
MaPPs
Choice and medication
NEWT guidelines
Ashtons
Contact Us
Careers
FAQs
Terms & Conditions
Statutory Licences
Privacy Policy
Cookie Policy

Start typing and press Enter to search